FDA's current thinking on operational strategy for implementation work plans. Presentation from workshops held on April 23 ~ 24, 2015 at the Washington Marriott Hotel, DC.
Food Safety Modernization Act: for importersLina Bush
The Food Safety Modernization Act is the largest overhaul of the U.S. food processing system in more than 80 years. Thought it impacts domestic and foreign producers, there are quite a few changes in the new law important for Importers & foreign food manufacturers. Here is a highlight on how FSMA impacts Imported foods.
Food Safety Modernization Act: for importersLina Bush
The Food Safety Modernization Act is the largest overhaul of the U.S. food processing system in more than 80 years. Thought it impacts domestic and foreign producers, there are quite a few changes in the new law important for Importers & foreign food manufacturers. Here is a highlight on how FSMA impacts Imported foods.
Learn what inspectors are looking for and how to prepare for inspections in eTMF. This deck will cover an inspections overview, inspection preparation, inspector access, and inspection readiness. For more info, visit http://bit.ly/VaulteTMF
OTC Business Process Review - achievements and opportunitiesTGA Australia
The presentation was given by the TGA at the 2014 ARCS Scientific Congress, and covers TGA's progress on the OTC Business Process Review, including strategies and identified future opportunities
The Magic of Internal Audits: Mistakes, Insights and Advice from the ExpertsSafetyChain Software
In this webinar, food safety and quality expert Jeff Strout (Merieux NutriSciences) will share hot topics, expert insights (including the “wow factor”), and critical components of robust internal auditing systems that are needed to drive continuous improvement.
Introduction types, Objectives, Management of audit, Responsibilities, Planni...Kunal10679
Audit and regulatory Compliance M.pharmacy Quality Assurance department Sem. 2 Introduction types, Objectives, Management of audit, Responsibilities, Planning Process, Information Gathering, Classifications of Deficiencies of auditing
If you are involved with Pharmacovigilance Audits or GPvP, you need to read this.
We also offer online courses for GPvP.. ask me for more details manish.kainth@infonetica.net
these are different entry strategies of companies to go global. also specified the need to go global and the time when the operations should be stopped in an international business,
Improve Regulatory Compliance & Risk Management Using Best PracticesLavante Inc.
Protect your companies' brand, add strategic value to AP, and assure your senior management that your vendor information is complete, accurate and compliant.
Mary Schaeffer from AP Now and Joe Flynn Founder of Lavante present how to:
* Improve Vendors relationships by enabling effective communication
* Define AP procedures for gathering credentials and ensuring government compliance
* Conduct an unbiased in-depth statement review process' to recover credits, erroneous payments, contract compliance, and more
* Leverage supplier portals to reduce costs and streamline AP processes
Fine out if you are using the best practices when it comes to your Government Regulation Compliance program. Or to watch the webinar on-demand, go here: http://bit.ly/1zAPxJC.
Presentation: An Update on post-market regulatory requirementsTGA Australia
Along with implementation of expedited medicine registration pathways TGA has undertaken enhancements to its post-market monitoring of medicines, with a focus on assisting sponsors meet their regulatory requirements. TGA's new Pharmacovigilance Inspection Program (PVIP) involves interviewing sponsors and reviewing documents in order to assess sponsors' level of compliance with pharmacovigilance obligations. Work is also ongoing with sponsors to determine how best to confirm risk management plan (RMP) commitments are being met. This presentation will provide further detail on how TGA is working with and assisting sponsors satisfy their regulatory requirements.
Powerful Statistical Tools in the Pharmaceutical and Medical Devices Industry...Minitab, LLC
The development of new drugs and medical devices follows well-established approval paths to make sure that they are safe when they reach the public. The U.S. FDA recommends five stages for the medical device and pharma development process, and some Asia Pacific countries' regulators suggest similar steps.
In this virtual hands-on workshop, Minitab Technical Services Manager Ming Dong will walk you through the Minitab Statistical Software and Minitab Workspace quality and visual tools that can be used in each stage. He will also take you through the common challenges faced by pharmaceutical and medical device manufacturers.
FDA's current thinking on operational strategy for implementation work plans. Presentation from workshops held on April 23 ~ 24, 2015 at the Washington Marriott Hotel, DC.
F & I Administration Processing Controls- An SSAE 16 Professionals PerspectiveGary Pennington
Review the highlights from Tim Roncevich and Kelvin Walker's presentation at the P & A Leadership Summit where they discussed Internal Controls Employed in F&I Practices.
FDA Update: Inspections, Observations and Metrics - OMTEC 2017April Bright
This FDA-focused presentation offers a glimpse into trends behind three initiatives that orthopaedic device professionals need to fully understand: inspections, Case for Quality and 483 Observations. First, a high-level view of FDA inspections will discuss methodology and implementation. Second, FDA’s observations of non-compliance will be discussed, pointing out important historical trends. Finally, as the industry matures, professionals should expect changes to the breadth and depth of FDA’s focus. This is where Case for Quality and the Medical Device Metrics Initiative will be covered. FDA has placed an increased emphasis on data and metrics. Gain insight into ways to leverage data to improve, monitor and control processes that drive quality improvement.
Medical Device Manufacturing and Product Quality ProgramEMMAIntl
The purpose of this webinar is to discuss the FDA’s voluntary medical device manufacturing and product quality pilot program, CMMI Institute’s role in it and how manufacturers will benefit from this program.
Learn what inspectors are looking for and how to prepare for inspections in eTMF. This deck will cover an inspections overview, inspection preparation, inspector access, and inspection readiness. For more info, visit http://bit.ly/VaulteTMF
OTC Business Process Review - achievements and opportunitiesTGA Australia
The presentation was given by the TGA at the 2014 ARCS Scientific Congress, and covers TGA's progress on the OTC Business Process Review, including strategies and identified future opportunities
The Magic of Internal Audits: Mistakes, Insights and Advice from the ExpertsSafetyChain Software
In this webinar, food safety and quality expert Jeff Strout (Merieux NutriSciences) will share hot topics, expert insights (including the “wow factor”), and critical components of robust internal auditing systems that are needed to drive continuous improvement.
Introduction types, Objectives, Management of audit, Responsibilities, Planni...Kunal10679
Audit and regulatory Compliance M.pharmacy Quality Assurance department Sem. 2 Introduction types, Objectives, Management of audit, Responsibilities, Planning Process, Information Gathering, Classifications of Deficiencies of auditing
If you are involved with Pharmacovigilance Audits or GPvP, you need to read this.
We also offer online courses for GPvP.. ask me for more details manish.kainth@infonetica.net
these are different entry strategies of companies to go global. also specified the need to go global and the time when the operations should be stopped in an international business,
Improve Regulatory Compliance & Risk Management Using Best PracticesLavante Inc.
Protect your companies' brand, add strategic value to AP, and assure your senior management that your vendor information is complete, accurate and compliant.
Mary Schaeffer from AP Now and Joe Flynn Founder of Lavante present how to:
* Improve Vendors relationships by enabling effective communication
* Define AP procedures for gathering credentials and ensuring government compliance
* Conduct an unbiased in-depth statement review process' to recover credits, erroneous payments, contract compliance, and more
* Leverage supplier portals to reduce costs and streamline AP processes
Fine out if you are using the best practices when it comes to your Government Regulation Compliance program. Or to watch the webinar on-demand, go here: http://bit.ly/1zAPxJC.
Presentation: An Update on post-market regulatory requirementsTGA Australia
Along with implementation of expedited medicine registration pathways TGA has undertaken enhancements to its post-market monitoring of medicines, with a focus on assisting sponsors meet their regulatory requirements. TGA's new Pharmacovigilance Inspection Program (PVIP) involves interviewing sponsors and reviewing documents in order to assess sponsors' level of compliance with pharmacovigilance obligations. Work is also ongoing with sponsors to determine how best to confirm risk management plan (RMP) commitments are being met. This presentation will provide further detail on how TGA is working with and assisting sponsors satisfy their regulatory requirements.
Powerful Statistical Tools in the Pharmaceutical and Medical Devices Industry...Minitab, LLC
The development of new drugs and medical devices follows well-established approval paths to make sure that they are safe when they reach the public. The U.S. FDA recommends five stages for the medical device and pharma development process, and some Asia Pacific countries' regulators suggest similar steps.
In this virtual hands-on workshop, Minitab Technical Services Manager Ming Dong will walk you through the Minitab Statistical Software and Minitab Workspace quality and visual tools that can be used in each stage. He will also take you through the common challenges faced by pharmaceutical and medical device manufacturers.
FDA's current thinking on operational strategy for implementation work plans. Presentation from workshops held on April 23 ~ 24, 2015 at the Washington Marriott Hotel, DC.
F & I Administration Processing Controls- An SSAE 16 Professionals PerspectiveGary Pennington
Review the highlights from Tim Roncevich and Kelvin Walker's presentation at the P & A Leadership Summit where they discussed Internal Controls Employed in F&I Practices.
FDA Update: Inspections, Observations and Metrics - OMTEC 2017April Bright
This FDA-focused presentation offers a glimpse into trends behind three initiatives that orthopaedic device professionals need to fully understand: inspections, Case for Quality and 483 Observations. First, a high-level view of FDA inspections will discuss methodology and implementation. Second, FDA’s observations of non-compliance will be discussed, pointing out important historical trends. Finally, as the industry matures, professionals should expect changes to the breadth and depth of FDA’s focus. This is where Case for Quality and the Medical Device Metrics Initiative will be covered. FDA has placed an increased emphasis on data and metrics. Gain insight into ways to leverage data to improve, monitor and control processes that drive quality improvement.
Medical Device Manufacturing and Product Quality ProgramEMMAIntl
The purpose of this webinar is to discuss the FDA’s voluntary medical device manufacturing and product quality pilot program, CMMI Institute’s role in it and how manufacturers will benefit from this program.
This presentation covers (1) Social impact of tourism; (2) Effects of globalization on tourism development; (3) Sex tourism and exploitation of women; and (4) Trends and issues shaping tourism and hospitality development.
Explore the Association for Vertical Farming infographics surrounding the topic of Urban and Vertical Farming. For more information, visit the Vertical Farming website: https://vertical-farming.net/
Ang Chong Yi Navigating Singaporean Flavors: A Journey from Cultural Heritage...Ang Chong Yi
In the heart of Singapore, where tradition meets modernity, He embarks on a culinary adventure that transcends borders. His mission? Ang Chong Yi Exploring the Cultural Heritage and Identity in Singaporean Cuisine. To explore the rich tapestry of flavours that define Singaporean cuisine while embracing innovative plant-based approaches. Join us as we follow his footsteps through bustling markets, hidden hawker stalls, and vibrant street corners.
Roti Bank Hyderabad: A Beacon of Hope and NourishmentRoti Bank
One of the top cities of India, Hyderabad is the capital of Telangana and home to some of the biggest companies. But the other aspect of the city is a huge chunk of population that is even deprived of the food and shelter. There are many people in Hyderabad that are not having access to
At Taste Of Middle East, we believe that food is not just about satisfying hunger, it's about experiencing different cultures and traditions. Our restaurant concept is based on selecting famous dishes from Iran, Turkey, Afghanistan, and other Arabic countries to give our customers an authentic taste of the Middle East
2. Past Import Paradigm
• Border focused
• Virtually all of the information used to
assess admissibility comes from the
import submission
• FDA makes a decision about the
compliance status of the product at the
time of entry with limited time, resources,
and information
2
3. Modernized Import System
• Focus on prevention
– The border can no longer be our primary line of
defense. It should only serve as a final checkpoint
on other controls
• FSMA creates a multilayered safety net
– Role of manufacturer
– Role of importers
– Role of third parties
– Role of foreign regulatory bodies
– Role of FDA
3
4. FSMA Imports-Related Sections
• Sec. 201. Inspection frequency
• Sec. 301. Foreign supplier verification program
• Sec. 302. Voluntary qualified importer program
• Sec. 303. Certification for food imports
• Sec. 304. Prior notice of imported food shipments
• Sec. 305. Capacity building
• Sec. 306. Inspection of foreign food facilities
• Sec. 307. Accreditation of third-party auditors
• Sec. 308. Foreign offices of the FDA
• Sec. 309. Smuggled food
• Sec. 404. Compliance with international agreements
4
6. Import Controls Phase II
Workgroup
Operational Areas in each sub-workgroup:
Inspections, Compliance and Enforcement │ Regulator Training │ Workforce Planning │
Information Technology │ External Outreach and Technical Assistance 6
8. Critical Operational
Considerations
• Work planning/staffing for industry oversight to help ensure
compliance, i.e. inspections, audits, sample collections and
import program data integration to target resources
• Industry/stakeholder education, outreach, and technical
assistance
• Regulator training and technical support
• IT, integration of domestic and import systems
• International trade context
• Requested $25.5 M in FY16 for modernized import system
8
9. FSVP: Inspections,
Compliance, Enforcement
• Accomplishments
– Developing inspectional protocol for importers
– Significant progress in identifying modifications to current
entry process
• Challenges
– Awaiting final rule publication
– Unknown inventory of importers
– Importers may not have been previously inspected by FDA
– Balancing “new” and “old” work as we transition
9
10. FSVP: Regulator Training
• Accomplishments
– Initial draft of a job task analysis for FDA staff
• Challenges
– Identifying and training FDA experts
– Identifying locations for regional training
hubs that work for FSVP and Preventive
Controls
10
11. FSVP: External Outreach
and Technical Assistance
•Accomplishments
– Developing a comprehensive outreach plan
(meetings, industry training, fact sheets, etc.)
•Challenges
– Reaching the appropriate audiences (Importer
awareness)
– Numerous requests for outreach and training
11
12. FSVP: Information Technology
• Accomplishments
– Developing data requirements for FDA
systems
– Developing “one-stop shop” to help importers
assess compliance status of suppliers
• Challenges
– Integration of IT systems
– FSMA rule interdependencies
12
13. FSVP: Workforce Planning
• Accomplishments
• Developing long-term staffing projections for FDA
• Challenges
– Projections may have to be modified once a true
inventory of importers subject to inspection is
developed
– Need to balance new import work with current
import work
13
14. Third Party: Compliance,
Enforcement
• Not an inspection program
• Accomplishments:
– Developing communication and operational strategies
linked with other FDA imports programs and foreign
inspections
• Challenges:
– Concurrent program development makes it difficult to
finalize strategies
14
15. Third Party: Regulator Training
• Accomplishments:
– Developed training strategy for FDA third-
party program staff that will include internal
and external training
• Challenges:
– Developing plans for FY 17-18 training
needs, which depend on program
participation
15
16. Third Party: External Outreach
and Technical Assistance
• Accomplishments:
– Outreach to certification bodies, scheme owners,
accreditation bodies, foreign governments, consumer
groups, trade associations, other stakeholders
• Challenges:
– Voluntary program
– New program needs significant outreach
– Identifying new stakeholders
16
17. Third Party: Information
Technology
• Accomplishments:
– Significant progress in building an integrated IT system
– Interface with imports operations and foreign inspections
– Support for VQIP and Import Certification
– Will accept external submissions, integrate with internal
systems, and serve as internal workflow manager
• Challenges:
– Business needs evolve while IT requirements lock down
17
18. Third Party: Workforce
Planning
• Accomplishments:
– Initial staffing needs identified
– Hiring approved in FY 15
• Challenges:
– Significant hiring demands across the food
and feed program
18